(NASDAQ: EMBC) Embecta's forecast annual revenue growth rate of 2.3% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.23%.
Embecta's revenue in 2026 is $1,042,500,000.On average, 6 Wall Street analysts forecast EMBC's revenue for 2026 to be $62,650,026,912, with the lowest EMBC revenue forecast at $59,019,173,080, and the highest EMBC revenue forecast at $66,743,636,625. On average, 6 Wall Street analysts forecast EMBC's revenue for 2027 to be $65,201,117,023, with the lowest EMBC revenue forecast at $62,175,405,496, and the highest EMBC revenue forecast at $67,455,568,749.
In 2028, EMBC is forecast to generate $65,853,721,470 in revenue, with the lowest revenue forecast at $62,412,716,204 and the highest revenue forecast at $68,642,122,289.